Indomethacin vs placebo or control
Bronchopulmonary dysplasia · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in bronchopulmonary dysplasia at 36 weeks' gestation compared with placebo or control (low certainty).
1 finding from 1 review
- Indomethacin for symptomatic patent ductus arteriosus in preterm infants 2021 · Cochrane Headline outcomes onlyRR 0.8 [0.41, 1.55]1 study · 92 participantsLow